decisionhealth Newsletters, Part B News - 2011 Issue 2 (February)
Ask a Part B News Expert: Billing for injections
Subscribe or sign in to view the full article.
Article Overview
This premium Q&A explains general billing considerations for injection administration in physician office settings when the patient brings the drug. It discusses how coding professionals may think about administration versus supply, how some carriers want the substance reported, and a specific carrier example involving chemotherapy administration reporting. The article is relevant to office-based coders, billers, and reimbursement staff who handle injectable drugs and payer documentation requirements.
Why This Topic Matters
Injection billing can involve separate reporting of administration and drug supply, and payer rules may vary on how no-charge substances are documented. Understanding the general guidance and carrier-specific reporting expectations helps reduce claim errors and supports medically necessary billing review.
What You Will Learn
- The distinction between injection administration and drug supply reporting
- How some carriers want patient-supplied injectable drugs documented
- That carrier-specific guidance may affect reporting practices for certain administration services
- How the article frames general billing considerations for physician office injection claims
Who Should Read This
- Medical coders
- Medical billers
- Practice managers
- Revenue cycle staff
- Compliance staff
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com